Cargando…
Parkinson’s disease recovery by GM1 oligosaccharide treatment in the B4galnt1(+/−) mouse model
Given the recent in vitro discovery that the free soluble oligosaccharide of GM1 is the bioactive portion of GM1 for neurotrophic functions, we investigated its therapeutic potential in the B4galnt1(+/−) mice, a model of sporadic Parkinson’s disease. We found that the GM1 oligosaccharide, systemical...
Autores principales: | Chiricozzi, Elena, Mauri, Laura, Lunghi, Giulia, Di Biase, Erika, Fazzari, Maria, Maggioni, Margherita, Valsecchi, Manuela, Prioni, Simona, Loberto, Nicoletta, Pomè, Diego Yuri, Ciampa, Maria Grazia, Fato, Pamela, Verlengia, Gianluca, Cattaneo, Stefano, Assini, Robert, Wu, Gusheng, Alselehdar, Samar, Ledeen, Robert W., Sonnino, Sandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6920361/ https://www.ncbi.nlm.nih.gov/pubmed/31852959 http://dx.doi.org/10.1038/s41598-019-55885-2 |
Ejemplares similares
-
GM1 Oligosaccharide Crosses the Human Blood–Brain Barrier In Vitro by a Paracellular Route
por: Di Biase, Erika, et al.
Publicado: (2020) -
Turning the spotlight on the oligosaccharide chain of GM1 ganglioside
por: Chiricozzi, Elena, et al.
Publicado: (2021) -
GM1 Oligosaccharide Efficacy in Parkinson’s Disease: Protection against MPTP
por: Fazzari, Maria, et al.
Publicado: (2023) -
Modulation of calcium signaling depends on the oligosaccharide of GM1 in Neuro2a mouse neuroblastoma cells
por: Lunghi, Giulia, et al.
Publicado: (2020) -
Novel insights on GM1 and Parkinson's disease: A critical review
por: Fazzari, Maria, et al.
Publicado: (2022)